BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 19474398)

  • 1. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression.
    Sung KR; Lee S; Park SB; Choi J; Kim ST; Yun SC; Kang SY; Cho JW; Kook MS
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5266-74. PubMed ID: 19474398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma.
    Choi J; Kim KH; Jeong J; Cho HS; Lee CH; Kook MS
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):104-11. PubMed ID: 17197523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma.
    Choi J; Jeong J; Cho HS; Kook MS
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):831-6. PubMed ID: 16505014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
    Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between 24-hour mean ocular perfusion pressure fluctuation and rate of paracentral visual field progression in normal-tension glaucoma.
    Choi J; Lee JR; Lee Y; Lee KS; Na JH; Han S; Kook MS
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6150-7. PubMed ID: 23963166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical factors associated with progression of normal-tension glaucoma.
    Ishida K; Yamamoto T; Kitazawa Y
    J Glaucoma; 1998 Dec; 7(6):372-7. PubMed ID: 9871858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between daytime variability of blood pressure or ocular perfusion pressure and glaucomatous visual field progression.
    Lee J; Choi J; Jeong D; Kim S; Kook MS
    Am J Ophthalmol; 2015 Sep; 160(3):522-537.e1. PubMed ID: 26052089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study.
    Leung DY; Tham CC; Li FC; Kwong YY; Chi SC; Lam DS
    Ophthalmology; 2009 Jul; 116(7):1250-6. PubMed ID: 19481813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.
    Lee PP; Walt JW; Rosenblatt LC; Siegartel LR; Stern LS;
    Am J Ophthalmol; 2007 Dec; 144(6):901-907. PubMed ID: 17919446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
    Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
    Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative change in diurnal mean ocular perfusion pressure: a risk factor for the diagnosis of primary open-angle glaucoma.
    Sehi M; Flanagan JG; Zeng L; Cook RJ; Trope GE
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):561-7. PubMed ID: 15671283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four hour (Nyctohemeral) rhythm of intraocular pressure and ocular perfusion pressure in normal-tension glaucoma.
    Renard E; Palombi K; Gronfier C; Pepin JL; Noel C; Chiquet C; Romanet JP
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):882-9. PubMed ID: 19684006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anterior optic nerve capillary blood flow response to diurnal variation of mean ocular perfusion pressure in early untreated primary open-angle glaucoma.
    Sehi M; Flanagan JG; Zeng L; Cook RJ; Trope GE
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4581-7. PubMed ID: 16303952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normotensive glaucoma and risk factors in normotensive eyes with pseudoexfoliation syndrome.
    Koz OG; Turkcu MF; Yarangumeli A; Koz C; Kural G
    J Glaucoma; 2009 Dec; 18(9):684-8. PubMed ID: 20010248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.